# DeepTek

> DeepTek develops radiology AI, imaging workflow software and remote reporting services for hospitals, diagnostic centers and public health programs. Its Augmento platform organizes imaging and AI deployment, while Genki supports chest X-ray screening for tuberculosis. The company combines medical imaging expertise with software engineering and global distribution partnerships.

- **Founded:** 2017
- **Headquarters:** Pune, India
- **Founders:** Ajit Patil (Co-founder and Managing Director), Dr. Amit Kharat (Co-founder and CEO)
- **Products:** Augmento Enterprise, Genki, DeepTek CXR Analyzer, Teleradiology, Responsible AI
- **Notable:** Augmento FDA 510(k) clearance K222781 on April 11, 2023., CXR Analyzer FDA clearance under K231001., Chest X-ray AI CE MDR Class IIb certification announced April 2025.

## Products & services

- **Augmento Enterprise** — Vendor-neutral cloud PACS and AI orchestration platform with structured reporting, collaboration and analytics; FDA clearance in 2023.
- **Genki** — Chest X-ray CAD for TB screening, with offline and online deployment, registration and screening dashboards.
- **DeepTek CXR Analyzer** — FDA-cleared computer-aided detection software that highlights suspicious chest X-ray findings for radiologists.
- **Teleradiology** — Pay-per-report remote radiologist coverage for X-ray, CT, MR and PET-CT, with quality review.
- **Responsible AI** — Post-deployment monitoring of model performance, demographic bias and drift, independent of model vendor.

## Achievements

- Augmento FDA 510(k) clearance K222781 on April 11, 2023.
- CXR Analyzer FDA clearance under K231001.
- Chest X-ray AI CE MDR Class IIb certification announced April 2025.
- Genki Edge v3.4.2 included among products meeting WHO TB CAD performance standards in 2025.
- Company reports 7 patents filed, 30+ research papers and 2,000+ global sites; patents filed are not patents granted.

## Latest updates

- **2026-09** — CHAI published detailed FAQ terms for the TB CAD access agreements.
- **2026-07** — Unitaid and CHAI announced lower-cost Genki access for eligible public and nonprofit buyers.
- **2025-06** — WHO’s CAD policy evaluation includes Genki Edge v3.4.2 among tools meeting TB screening performance standards.
- **2025-04** — DeepTek announced CE MDR Class IIb certification for chest X-ray AI.
- **2024-11** — Blackford announced commercial distribution partnership for CXR Analyzer.

## Links

- Website: https://www.deeptek.ai/
- LinkedIn: https://www.linkedin.com/company/deeptek/
- Twitter/X: https://x.com/DeepTekAI
- YouTube: https://www.youtube.com/channel/UCHk_BAI1RqVdQg7jXY_K2vg/featured
- Instagram: https://www.instagram.com/deeptek.ai/
- Facebook: https://facebook.com/deeptekinfo/

---

Profile page: https://yespress.io/deeptek
Published by YesPress — https://yespress.io
Last updated: 2026-10-04